IO Biotech Inc.

NASDAQ: IOBT · Real-Time Price · USD
2.10
-0.06 (-2.78%)
At close: Aug 18, 2025, 3:59 PM
2.10
0.00%
After-hours: Aug 18, 2025, 07:59 PM EDT

IO Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
37.09M 60.03M 80.19M 100.75M 117.98M 143.19M 165.5M 110.09M 128.53M 142.59M 151.17M 170.12M 187.9M 211.53M 45.48M 54.75M -3.4M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.81M
Long-Term Investments
n/a n/a n/a n/a 268K 268K 268K 268K 268K 268K n/a 268K 268K 268K n/a n/a n/a
Other Long-Term Assets
1.19M 385K 1.19M 1.14M 883K 89K 867K 891K 876K 84K 1.15M 910K 136K 127K 45K 38K -3.4M
Receivables
922K 1.13M 964K 1.03M 909K 1.13M 954K 1.2M 1.01M 1.53M 1.09M 2.07M 2.79M 2.09M 2.12M n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a -954K 929K 1.73M -1.53M 5.18M 6.57M 8.27M -2.09M 4.04M 217K n/a
Other Current Assets
1.92M 803K 933K 774K 911K 754K 680K 814K 1.01M 685K 313K 201K 281K 149K 2.77M 3.74M n/a
Total Current Assets
42.34M 64.95M 86.24M 107.65M 124.13M 147.25M 168.25M 113.04M 132.27M 148.22M 157.75M 178.96M 199.25M 221.74M 51.99M 58.5M 3.4M
Property-Plant & Equipment
2.2M 2.36M 2.51M 2.67M 2.88M 3.11M 3.16M 3.36M 3.43M 3.23M 3.25M 2.51M 2.52M 155K n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
3.39M 2.75M 3.7M 3.81M 4.03M 3.46M 4.3M 4.52M 4.58M 3.59M 4.41M 3.68M 2.92M 550K 45K 38K -3.4M
Total Assets
45.74M 67.7M 89.94M 111.47M 128.16M 150.72M 172.55M 117.56M 136.84M 151.81M 162.16M 182.65M 202.17M 222.29M 52.04M 58.53M n/a
Account Payables
5.2M 4.66M 5.26M 5.02M 3.84M 3.88M 6.64M 4.46M 4.26M 4M 2.35M 4.54M 2.09M 3.93M 2.17M 1.7M n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a 4.83M n/a n/a 3.04M n/a n/a n/a -28.28M n/a n/a
Short-Term Debt
n/a 717K n/a 678K n/a 655K 627K 613K 559K 515K 492K 419K 345K n/a n/a n/a n/a
Other Current Liabilities
3M 5.04M 6.55M 4.83M 5M 6.3M 2.49M 2.25M 3.72M 3.78M 1.55M 1.93M 3.03M 461K 29.16M 32.77M n/a
Total Current Liabilities
18.29M 19.49M 16.05M 13.72M 11.04M 15.72M 12.98M 10.88M 10.36M 10.68M 6.32M 8.55M 6.43M 10.3M 33.79M 38.95M n/a
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 59K n/a n/a n/a
Total Long-Term Liabilities
1.03M 1.2M 1.32M 1.47M 1.65M 1.84M 1.98M 2.16M 2.27M 2.27M 2.35M 1.92M 2.05M 59K 37.91M 37.91M n/a
Total Liabilities
19.31M 20.68M 17.38M 15.2M 12.69M 17.56M 14.96M 13.04M 12.63M 12.95M 8.67M 10.47M 8.48M 10.36M 71.69M 76.86M n/a
Total Debt
1.76M 1.92M 2.02M 2.15M 2.32M 2.49M 2.6M 2.77M 2.83M 2.79M 2.84M 2.34M 2.39M n/a 28.28M n/a n/a
Common Stock
66K 66K 66K 66K 66K 66K 66K 29K 29K 29K 29K 29K 29K 29K 28K 28K n/a
Retained Earnings
-381.73M -359.31M -327.98M -303.96M -283.28M -263.82M -237.64M -215.96M -194.78M -177.74M -157.67M -141.98M -123.48M -106.28M -84.97M -83.88M n/a
Comprehensive Income
-6.59M -6.85M -11M -9.63M -9.47M -9.67M -9.87M -9.77M -9.62M -10.14M -13.92M -8.52M -4.14M -1.49M 705K 1.42M -35.3M
Shareholders Equity
26.42M 47.02M 72.56M 96.27M 115.47M 133.16M 157.59M 104.52M 124.22M 138.85M 153.49M 172.18M 193.69M 211.92M -19.65M -18.33M 2.6M
Total Investments
n/a n/a n/a 268K 268K 268K 268K 268K 268K 268K n/a 268K 268K 268K n/a n/a 6.81M